2024-01-17 |
2024-01-16 |
S
Sale
|
DeVaul William
General Counsel and Secretary
Officer
|
4,509
-16.4%
27.49
123,956
USD
|
4,509
-16.4%
|
27.49
|
123,956
USD
|
|
2024-01-17 |
2024-01-16 |
S
Sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
6,041
-13.9%
27.49
166,071
USD
|
6,041
-13.9%
|
27.49
|
166,071
USD
|
|
2024-01-17 |
2024-01-16 |
S
Sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
5,089
-12.7%
27.49
139,900
USD
|
5,089
-12.7%
|
27.49
|
139,900
USD
|
|
2024-01-17 |
2024-01-16 |
S
Sale
|
Tipirneni Praveen P.
CEO
Executive Director
|
13,923
-24.9%
27.49
382,753
USD
|
13,923
-24.9%
|
27.49
|
382,753
USD
|
|
2024-01-17 |
2024-01-16 |
S
Sale
|
Rogers Bruce
President
Officer
|
6,314
-4.3%
27.49
173,576
USD
|
6,314
-4.3%
|
27.49
|
173,576
USD
|
|
2023-11-15 |
2023-11-13 |
B
Purchase
|
Edwards Martin
Non-Executive Director
|
2,376
+inf%
20.54
48,803
USD
|
2,376
+inf%
|
20.54
|
48,803
USD
|
|
2023-11-14 |
2023-11-13 |
B
Purchase
|
SLATTERY JOSEPH P
Non-Executive Director
|
2,400
+36.0%
20.60
49,436
USD
|
2,400
+36.0%
|
20.60
|
49,436
USD
|
|
2023-09-08 |
2023-09-07 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
13,309
-35.5%
54.92
730,885
USD
|
13,309
-35.5%
|
54.92
|
730,885
USD
|
|
2023-09-08 |
2023-09-07 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
6,691
-15.2%
53.20
355,964
USD
|
6,691
-15.2%
|
53.20
|
355,964
USD
|
|
2023-08-03 |
2023-08-01 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
493
-3.4%
57.94
28,566
USD
|
493
-3.4%
|
57.94
|
28,566
USD
|
|
2023-08-03 |
2023-08-01 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
1,638
-10.2%
57.42
94,052
USD
|
1,638
-10.2%
|
57.42
|
94,052
USD
|
|
2023-08-03 |
2023-08-01 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
1,466
-8.4%
56.32
82,569
USD
|
1,466
-8.4%
|
56.32
|
82,569
USD
|
|
2023-07-06 |
2023-07-03 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
3,597
-20.5%
57.04
205,178
USD
|
3,597
-20.5%
|
57.04
|
205,178
USD
|
|
2023-06-14 |
2023-06-12 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
840
-5.7%
63.01
52,929
USD
|
840
-5.7%
|
63.01
|
52,929
USD
|
|
2023-06-09 |
2023-06-07 |
PS
Planned sale
|
DeVaul William
General Counsel and Secretary
Officer
|
7,756
-36.8%
60.05
465,742
USD
|
7,756
-36.8%
|
60.05
|
465,742
USD
|
|
2023-06-02 |
2023-06-01 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
1,609
-10.4%
57.64
92,737
USD
|
1,609
-10.4%
|
57.64
|
92,737
USD
|
|
2023-06-02 |
2023-06-01 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
1,988
-11.3%
56.73
112,782
USD
|
1,988
-11.3%
|
56.73
|
112,782
USD
|
|
2023-05-25 |
2023-05-24 |
PS
Planned sale
|
DeVaul William
General Counsel and Secretary
Officer
|
100
-0.5%
60.00
6,000
USD
|
100
-0.5%
|
60.00
|
6,000
USD
|
|
2023-05-25 |
2023-05-23 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
10,000
-29.7%
60.00
600,000
USD
|
10,000
-29.7%
|
60.00
|
600,000
USD
|
|
2023-05-25 |
2023-05-23 |
PS
Planned sale
|
DeVaul William
General Counsel and Secretary
Officer
|
3,802
-15.2%
60.03
228,236
USD
|
3,802
-15.2%
|
60.03
|
228,236
USD
|
|
2023-05-05 |
2023-05-03 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
3,597
-20.5%
51.11
183,857
USD
|
3,597
-20.5%
|
51.11
|
183,857
USD
|
|
2023-05-04 |
2023-05-03 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
1,050,000
+61.1%
45.00
47,250,000
USD
|
1,050,000
+61.1%
|
45.00
|
47,250,000
USD
|
|
2023-04-27 |
2023-04-25 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
10,000
-45.0%
54.71
547,100
USD
|
10,000
-45.0%
|
54.71
|
547,100
USD
|
|
2023-04-27 |
2023-04-25 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
50,000
-67.4%
54.71
2,735,500
USD
|
50,000
-67.4%
|
54.71
|
2,735,500
USD
|
|
2023-04-27 |
2023-04-25 |
PS
Planned sale
|
Rogers Bruce
President
Officer
|
30,000
-20.4%
53.40
1,602,129
USD
|
30,000
-20.4%
|
53.40
|
1,602,129
USD
|
|
2023-04-27 |
2023-04-25 |
PS
Planned sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
25,179
-64.4%
53.40
1,344,667
USD
|
25,179
-64.4%
|
53.40
|
1,344,667
USD
|
|
2023-04-21 |
2023-04-20 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
10,000
-45.0%
45.00
450,000
USD
|
10,000
-45.0%
|
45.00
|
450,000
USD
|
|
2023-04-19 |
2023-04-17 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
10,000
-81.8%
42.50
425,001
USD
|
10,000
-81.8%
|
42.50
|
425,001
USD
|
|
2023-04-19 |
2023-04-17 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
10,000
-45.0%
40.00
400,000
USD
|
10,000
-45.0%
|
40.00
|
400,000
USD
|
|
2023-04-19 |
2023-04-17 |
PS
Planned sale
|
Rogers Bruce
President
Officer
|
10,000
-7.9%
40.35
403,463
USD
|
10,000
-7.9%
|
40.35
|
403,463
USD
|
|
2023-03-09 |
2023-03-07 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
50,000
-74.5%
45.00
2,250,050
USD
|
50,000
-74.5%
|
45.00
|
2,250,050
USD
|
|
2023-02-16 |
2023-02-14 |
PS
Planned sale
|
Rogers Bruce
President
Officer
|
10,000
-7.9%
40.09
400,901
USD
|
10,000
-7.9%
|
40.09
|
400,901
USD
|
|
2023-01-18 |
2023-01-14 |
S
Sale
|
DeVaul William
General Counsel and Secretary
Officer
|
1,169
-4.7%
30.63
35,805
USD
|
1,169
-4.7%
|
30.63
|
35,805
USD
|
|
2023-01-18 |
2023-01-14 |
S
Sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
1,670
-9.3%
30.63
51,150
USD
|
1,670
-9.3%
|
30.63
|
51,150
USD
|
|
2023-01-18 |
2023-01-14 |
S
Sale
|
Rogers Bruce
President
Officer
|
1,778
-1.5%
30.63
54,458
USD
|
1,778
-1.5%
|
30.63
|
54,458
USD
|
|
2023-01-18 |
2023-01-14 |
S
Sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
1,248
-5.3%
30.63
38,224
USD
|
1,248
-5.3%
|
30.63
|
38,224
USD
|
|
2023-01-18 |
2023-01-14 |
S
Sale
|
Tipirneni Praveen P.
President and CEO
Executive Director
|
4,027
-24.1%
30.63
123,338
USD
|
4,027
-24.1%
|
30.63
|
123,338
USD
|
|
2022-04-01 |
2022-04-01 |
PS
Planned sale
|
Rogers Bruce
Chief Scientific Officer
Officer
|
2,625
-2.5%
41.42
108,724
USD
|
2,625
-2.5%
|
41.42
|
108,724
USD
|
|
2022-04-01 |
2022-04-01 |
PS
Planned sale
|
Rogers Bruce
Chief Scientific Officer
Officer
|
7,375
-6.5%
40.89
301,556
USD
|
7,375
-6.5%
|
40.89
|
301,556
USD
|
|
2021-11-03 |
2021-11-01 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
5,477
-45.6%
60.00
328,620
USD
|
5,477
-45.6%
|
60.00
|
328,620
USD
|
|
2021-10-28 |
2021-10-26 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
37
-0.6%
60.00
2,220
USD
|
37
-0.6%
|
60.00
|
2,220
USD
|
|
2021-10-15 |
2021-10-15 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
3,338
-33.8%
60.00
200,280
USD
|
3,338
-33.8%
|
60.00
|
200,280
USD
|
|
2021-10-15 |
2021-10-14 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
24,184
-78.7%
60.02
1,451,446
USD
|
24,184
-78.7%
|
60.02
|
1,451,446
USD
|
|
2021-10-15 |
2021-10-13 |
PS
Planned sale
|
SCHEGERIN MARC
CFO and COO
Officer
|
1,964
-23.1%
60.00
117,845
USD
|
1,964
-23.1%
|
60.00
|
117,845
USD
|
|
2021-09-17 |
2021-09-16 |
S
Sale
|
Linde Peter
Chief Medical Officer
Officer
|
624
-5.2%
67.00
41,805
USD
|
624
-5.2%
|
67.00
|
41,805
USD
|
|
2021-09-17 |
2021-09-16 |
S
Sale
|
Linde Peter
Chief Medical Officer
Officer
|
3,276
-21.6%
66.48
217,803
USD
|
3,276
-21.6%
|
66.48
|
217,803
USD
|
|
2021-09-17 |
2021-09-16 |
S
Sale
|
Linde Peter
Chief Medical Officer
Officer
|
100
-0.7%
64.29
6,429
USD
|
100
-0.7%
|
64.29
|
6,429
USD
|
|
2021-09-14 |
2021-09-13 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
3,049
-23.4%
65.01
198,202
USD
|
3,049
-23.4%
|
65.01
|
198,202
USD
|
|
2021-09-13 |
2021-09-13 |
PS
Planned sale
|
Rogers Bruce
Chief Scientific Officer
Officer
|
1,721
-1.9%
65.00
111,873
USD
|
1,721
-1.9%
|
65.00
|
111,873
USD
|
|
2021-09-14 |
2021-09-10 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
9,859
-43.0%
65.14
642,166
USD
|
9,859
-43.0%
|
65.14
|
642,166
USD
|
|
2021-09-13 |
2021-09-10 |
PS
Planned sale
|
Rogers Bruce
Chief Scientific Officer
Officer
|
8,279
-8.4%
65.11
539,078
USD
|
8,279
-8.4%
|
65.11
|
539,078
USD
|
|
2021-09-13 |
2021-09-09 |
PS
Planned sale
|
Rogers Bruce
Chief Scientific Officer
Officer
|
6,086
-6.3%
61.60
374,918
USD
|
6,086
-6.3%
|
61.60
|
374,918
USD
|
|
2021-09-13 |
2021-09-09 |
PS
Planned sale
|
Rogers Bruce
Chief Scientific Officer
Officer
|
22,213
-18.8%
60.87
1,352,136
USD
|
22,213
-18.8%
|
60.87
|
1,352,136
USD
|
|
2021-09-13 |
2021-09-09 |
PS
Planned sale
|
Rogers Bruce
Chief Scientific Officer
Officer
|
1,701
-1.4%
59.99
102,039
USD
|
1,701
-1.4%
|
59.99
|
102,039
USD
|
|
2021-08-20 |
2021-08-20 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
11,511
+1.3%
56.80
653,839
USD
|
11,511
+1.3%
|
56.80
|
653,839
USD
|
|
2021-08-20 |
2021-08-20 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
109
+0.0%
56.01
6,105
USD
|
109
+0.0%
|
56.01
|
6,105
USD
|
|
2021-08-20 |
2021-08-19 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
13,874
+1.6%
56.82
788,339
USD
|
13,874
+1.6%
|
56.82
|
788,339
USD
|
|
2021-08-20 |
2021-08-19 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
18,916
+2.2%
56.31
1,065,183
USD
|
18,916
+2.2%
|
56.31
|
1,065,183
USD
|
|
2021-08-20 |
2021-08-19 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
210
+0.0%
54.71
11,488
USD
|
210
+0.0%
|
54.71
|
11,488
USD
|
|
2021-08-20 |
2021-08-18 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
9,208
+1.1%
56.35
518,845
USD
|
9,208
+1.1%
|
56.35
|
518,845
USD
|
|
2021-08-20 |
2021-08-18 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
21,099
+2.5%
55.42
1,169,357
USD
|
21,099
+2.5%
|
55.42
|
1,169,357
USD
|
|
2021-06-21 |
2021-06-18 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
200
-1.1%
65.00
13,000
USD
|
200
-1.1%
|
65.00
|
13,000
USD
|
|
2021-06-21 |
2021-06-16 |
PS
Planned sale
|
Farrell Robert E Jr
SVP Finance and CAO
Officer
|
300
-1.6%
65.00
19,501
USD
|
300
-1.6%
|
65.00
|
19,501
USD
|
|
2021-06-03 |
2021-06-01 |
PS
Planned sale
|
Linde Peter
Chief Medical Officer
Officer
|
1,352
-22.7%
50.30
68,010
USD
|
1,352
-22.7%
|
50.30
|
68,010
USD
|
|
2021-06-03 |
2021-06-01 |
PS
Planned sale
|
Linde Peter
Chief Medical Officer
Officer
|
4,648
-43.8%
49.72
231,100
USD
|
4,648
-43.8%
|
49.72
|
231,100
USD
|
|
2021-05-25 |
2021-05-21 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Major owner
|
232,295
+48.9%
45.50
10,569,423
USD
|
232,295
+48.9%
|
45.50
|
10,569,423
USD
|
|
2021-05-03 |
2021-04-30 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
2,855
-0.1%
55.73
159,109
USD
|
2,855
-0.1%
|
55.73
|
159,109
USD
|
|
2021-05-03 |
2021-04-30 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
5,274
-0.3%
55.04
290,281
USD
|
5,274
-0.3%
|
55.04
|
290,281
USD
|
|
2021-05-03 |
2021-04-30 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
1,358
-0.1%
54.26
73,685
USD
|
1,358
-0.1%
|
54.26
|
73,685
USD
|
|
2021-05-03 |
2021-04-29 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
1,114
-0.1%
55.23
61,526
USD
|
1,114
-0.1%
|
55.23
|
61,526
USD
|
|
2021-05-03 |
2021-04-29 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
2,731
-0.1%
54.51
148,867
USD
|
2,731
-0.1%
|
54.51
|
148,867
USD
|
|
2021-05-03 |
2021-04-29 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
3,826
-0.2%
53.37
204,194
USD
|
3,826
-0.2%
|
53.37
|
204,194
USD
|
|
2021-04-27 |
2021-04-26 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
1,273
-0.1%
57.28
72,917
USD
|
1,273
-0.1%
|
57.28
|
72,917
USD
|
|
2021-04-27 |
2021-04-26 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
2,538
-0.1%
56.71
143,930
USD
|
2,538
-0.1%
|
56.71
|
143,930
USD
|
|
2021-04-27 |
2021-04-26 |
PS
Planned sale
|
Omega Fund V, L.P.
Non-Executive Director
|
1,335
-0.1%
55.54
74,146
USD
|
1,335
-0.1%
|
55.54
|
74,146
USD
|
|